top of page

Membrane nanoparticles acts as a bait to trap SARS-CoV-2

The relentless coronavirus disease (COVID-19) pandemic quickly prompted the pursuit of novel effective therapeutic agents against the highly virulent SARS-CoV-2 virus. One of the prime targets for researchers is the angiotensin-converting enzyme 2 (ACE2), the primary receptor for SARS-CoV-2 spike glycoprotein (S1 subunit), which mediates viral entry into host cells. Read More



Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page